| 000 | 01281 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250511234413.0 | ||
| 264 | 0 | _c19900611 | |
| 008 | 199006s 0 0 eng d | ||
| 022 | _a0009-7330 | ||
| 024 | 7 |
_a10.1161/01.res.66.5.1449 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMak, I T | |
| 245 | 0 | 0 |
_aComparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. _h[electronic resource] |
| 260 |
_bCirculation research _cMay 1990 |
||
| 300 |
_a1449-52 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aLipid Peroxides _xantagonists & inhibitors |
| 650 | 0 | 4 | _aOsmolar Concentration |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 |
_aSarcolemma _xmetabolism |
| 700 | 1 | _aWeglicki, W B | |
| 773 | 0 |
_tCirculation research _gvol. 66 _gno. 5 _gp. 1449-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.res.66.5.1449 _zAvailable from publisher's website |
| 999 |
_c2341114 _d2341114 |
||